Please use this identifier to cite or link to this item:
http://20.193.157.4:9595/xmlui/handle/123456789/1239Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Mangalagi SS, Gajul SV Mohite ST Kakade SV | - |
| dc.date.accessioned | 2019-11-14T06:18:38Z | - |
| dc.date.available | 2019-11-14T06:18:38Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.issn | 22314261 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/1239 | - |
| dc.description.abstract | Resistance to cephalosporins due to β-lactamases is a major concern worldwide. However recent trend is to use β-lactamase inhibitor combinations. Potential combination is cefiximeclavulanate. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | BLDE(Deemed to be University) | en_US |
| dc.subject | Comparative AST, FDC, ESBL producing K. pneumoniae, Cefixime‑clavulanate | en_US |
| dc.title | Evaluation of cefixime-clavulanate combination by comparative disk diffusion method in klebsiella pneumoniae clinical isolates-An in-vitro study. | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Faculty of Microbiology | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.